首页> 外文期刊>Virchows Archiv: an international journal of pathology >Guidelines on processing and reporting of prostate biopsies: The 2013 update of the pathology committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC)
【24h】

Guidelines on processing and reporting of prostate biopsies: The 2013 update of the pathology committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC)

机译:前列腺活检的处理和报告指南:欧洲前列腺癌筛查随机研究(ERSPC)病理学委员会2013年更新

获取原文
获取原文并翻译 | 示例
           

摘要

The histopathological examination of a prostate biopsy is the basis of prostate cancer diagnostics. Prostate cancer grade and extent of cancer in the diagnostic biopsy are important determinants of patient management. Quality of the prostate biopsy and its processing may influence the outcome of the histopathological evaluation. Further, an unambiguous and concise pathology reporting is essential for an appropriate clinical decision process. Since our initial report in 2003, there have been several practice changes, including the increased uptake of follow-up biopsies of patients who are under active surveillance, increasingly taken under guidance of MRI, or who underwent a prostate-sparing therapy. Therefore, we investigated the literature on the current pathology practices and recommendations with regard to prostate biopsy processing and reporting, both at initial diagnosis and in the context of follow-up biopsies in order to update our guidelines on the optimal processing and reporting of prostate biopsies.
机译:前列腺活检的组织病理学检查是前列腺癌诊断的基础。诊断性活检中前列腺癌的级别和癌症程度是患者管理的重要决定因素。前列腺活检的质量及其处理过程可能会影响组织病理学评估的结果。此外,明确而简明的病理报告对于适当的临床决策过程至关重要。自从我们在2003年发表初次报告以来,已经发生了一些实践变化,包括接受主动监测,在MRI指导下接受越来越多的患者或进行了前列腺保留疗法的患者的随访活检的摄取有所增加。因此,我们在初始诊断和随访活检的背景下研究了有关前列腺活检处理和报告的当前病理学实践和建议的文献,以更新我们关于前列腺活检的最佳处理和报告的指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号